Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Story | Imugene Limited
Imugene Azer-cel CAR-T Trial Featured on 10 News | Patient Stor…
9.9K views1 month ago
linkedin.com
Imugene prepares pivotal azer-cel trial with FDA
Imugene prepares pivotal azer-cel trial with FDA
5 months ago
proactiveinvestors.com.au
Imugene gets FDA backing for azer-cel treatment
Imugene gets FDA backing for azer-cel treatment
4 months ago
proactiveinvestors.com.au
FDA backs Imugene’s azer-cel treatment plan - ICYMI
FDA backs Imugene’s azer-cel treatment plan - ICYMI
3 months ago
proactiveinvestors.com
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
5 months ago
proactiveinvestors.com
Leslie Chong on Imugene’s 83% Response Rates Path to FDA Approval | Fear Greed | Imugene Limited
Leslie Chong on Imugene’s 83% Response Rates Path to FDA Appr…
9.9K views3 weeks ago
linkedin.com
Imugene highlights azer-cel progress as trial patient enters remission
Imugene highlights azer-cel progress as trial patient enters re…
1 month ago
proactiveinvestors.com.au
Imugene secures $2.7m R&D tax refund to support clinical programs
1 month ago
proactiveinvestors.com.au
Leslie Chong, Imugene CEO - Money News
9 months ago
omny.fm
Imugene teams with ABL to bring VAXINIA into next clinical chapter
Oct 18, 2022
proactiveinvestors.com.au
Imugene doses first combination patient in lung cancer clinical trial
May 31, 2023
proactiveinvestors.com.au
Imugene has cancer vaccine trial data published in prestigious med…
Feb 25, 2019
proactiveinvestors.com.au
Imugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial …
Dec 5, 2023
proactiveinvestors.com.au
Imugene welcomes positive FDA feedback on improved manufactur…
Sep 10, 2023
proactiveinvestors.com.au
Imugene receives positive early results, including a 'complete resp…
6 months ago
proactiveinvestors.com
Imugene seeks to activate immune system of cancer patients to identi…
Jul 19, 2023
proactiveinvestors.com
Imugene well positioned to deliver 2024 milestones
Dec 29, 2023
proactiveinvestors.com.au
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Nov 27, 2023
proactiveinvestors.com.au
Imugene’s $20 million boost and cancer trial updates
Feb 2, 2025
proactiveinvestors.com.au
Imugene doses first patient in Phase 2 clinical trial
2 viewsSep 8, 2022
proactiveinvestors.com.au
Imugene off to strong start to 2023 with JP Morgan Healthcare Confer…
Jan 22, 2023
proactiveinvestors.com.au
Imugene sees positive early signals in Phase 1 VAXINIA study
Nov 5, 2023
proactiveinvestors.com.au
Groundbreaking cancer trial: Imugene’s CF33 advances in clini…
Nov 13, 2024
proactiveinvestors.com.au
Imugene posts HY net loss attributable A$37.8 million
1 month ago
marketscreener.com
Imugene achieves ‘complete response’ with mid dose cancer trial
Jan 19, 2024
proactiveinvestors.com
Imugene's CMO John Byon on latest cancer trial data
10 months ago
proactiveinvestors.com.au
Imugene gets development roadmap for cancer vaccine from FDA meet…
Mar 20, 2019
proactiveinvestors.com.au
Imugene with Proactive at ASX Small and Mid Cap Conference
Mar 26, 2024
proactiveinvestors.com.au
Just the Facts: Imugene receives Orphan Drug Designation for VAXI…
Sep 19, 2024
proactiveinvestors.com.au
Imugene expands bile tract cancer study as patient shows complete r…
Apr 15, 2024
proactiveinvestors.com.au
See more videos
Static thumbnail place holder